Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Reiterating a point made by someone else on here RE lack of mention of antibodies in the interview, noticably hush hush?
"04/5/2024
11:09 You'll have noted that antibodies were glossed over.Worth remembering there are five possible deals under discussion. Maybe the first of them next week?
markingtime"
@marcusl2 - for some reason your comment is getting the "Show additional replies, including those that may contain offensive content". Might be worth reposting it with some changes.
Now on twitter:
https://twitter.com/BiotechTVHQ/status/1786276690102046945
1700 views already.
Interesting after hours trade too it seems.
Tidy up of my post:
"...Therefore it would be wrong to write Scancell off for the next 4 to 6 months as good news is not exclusive to the trial updates"
Chester has hit the nail on the head with this post IMO.
Surprised so many are focused on this viewpoint RE everything depending on SCib trial results*?
Have people forgotten everything else going on and the fact have multiple avenues ongoing?
As we are all aware, they have been noticeably quiet of late too.
...and the fact Scancell have multiple avenues?
"Therefore it would be wrong to write Scancell off for the next 4 to 6 months as good news is not exclusive to the trial updates"
This exactly. Surprised so many are focused on this viewpoint. Have people forgotten everything else going on and the fact
Lol....I was going to make a similar comment. How come no mention yet of the "buyer" and lot sizes :)
311k.
I stand corrected Lofas, apologies. It is hugely frustrating for us LTH's I agree, however just in my opinion, in the grand scheme of things whether the price is 9p, 10p, 11p, 12p, even 15p is somewhat irrelevant.
It is a great price for newbies though, which is no comfort for us LTH's though.
@lofas - I take you sold up a while back and are looking for a cheaper buy in?
The similar lack of news/RNS's isn't helping the SP either it seems.
Nice find. Brad Locar seems to be one of the most followed bio reporters does he not?
I knew it was expensive, but not that expensive?
"New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours... but experts fear NHS can't afford them"
https://www.dailymail.co.uk/health/article-13353713/New-400-000-melanoma-vaccine-heralds-start-cancer-renaissance-UK-trials-personalised-jabs-lung-bowel-pancreas-liver-tumours-experts-fear-NHS-afford-them.html?ico=topics_pagination_mobile
CW...yes you'd think the likes of NICE/NHS would definitely prefer something off the shelf and far cheaper than the very costly personalised approach.
A whiff of desperation (i.e. ill thought out comments ) in quite a few posts of late IMO.
Interesting.
@Dalester + Jambion + Burble. Wondering the same sort of thing. These conference attendances would have confirmed months and months ago you'd think, so obligated to attend?
Also, very odd that the CFO went to present what was a scientific presentation?
@lofas I too am very frustrated at this weird situation of no updates but attendance of conferences. But your post is a huge overreaction IMO.
"We all have different personal circumstances and investment goals. If I had the choice of a guaranteed 50p next week versus a chance of £2.40 in 5 years, I'd go for the 50p. That's not because I don't think £2.40 is achievable but simply because my personal circumstances mean the money would be more use earlier rather than later. Plus the fact I've already held for 12 years!"
Fair enough RR. I just don't see Redmile/Vulpes accepting an offer that low IMO.
Yes...the double/triple WWE tag team as ever.